MDXG in the 13F filings

Mimedx Group Inc · CUSIP 602496101

Sector · Medical devices and instruments Theme · Healthcare: biopharma and medtech· L3VLUP-defined Theme · Surgical, medical and electromedical devices

Quarter

Q2 2024 Q1 2024 Q4 2023 Q1 2021 Q4 2020 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017

Quarter end: 31 Mar 2024; the date the book describes
Filed: 15 May 2024; latest of these filings; the earliest 15 May 2024
Managers listing it: 2; at least, of 95 tracked, among listed positions
Comparable managers: 93; filed both Q4 2023 and Q1 2024; 1 listed it in both
Shares listed: 259,504; combined, among listed positions
Reported value: $2.0m; combined, at the quarter end

Among the 93 comparable managers: 2 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +201,038.

Managers listing MDXG in Q1 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

ActionShare of book at least

2 of 2 holders

				Action		Filing
Caxton Associates LLP	132,155	$1.0m	0.06%	New	new	15 May 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP	127,349	$981k	under 0.1%	Added	+68,883	15 May 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2023 to Q1 2024, among managers that listed it in both quarters or opened it.

Increases

Caxton Associates LLPnew position · 132,155 shares now+132,155
Brevan Howard Capital Management LPexisting position · 127,349 shares now+68,883

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Caxton Associates LLP$1.0m

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.

2 in Q2 2018 to 1 in Q2 2024

Tracked managers listing it, at least.

the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.

MDXG by quarter
Quarter	Holders	Reported value	Buyers	Sellers
Q4 2013	2	$22m	n.a.	n.a.
Q2 2014	1	$6.4m	n.a.	n.a.
Q3 2014	1	$5.9m	n.a.	n.a.
Q4 2014	1	$30m	n.a.	n.a.
Q1 2015	1	$9.8m	n.a.	n.a.
Q2 2015	1	$9.7m	n.a.	n.a.
Q3 2015	2	$8.2m	n.a.	n.a.
Q4 2015	1	$8.5m	n.a.	n.a.
Q2 2017	4	$25m	n.a.	n.a.
Q3 2017	2	$14m	n.a.	n.a.
Q4 2017	2	$23m	n.a.	n.a.
Q1 2018	4	$16m	n.a.	n.a.
Q2 2018	2	$12m	n.a.	n.a.
Q3 2018	1	$8.5m	n.a.	n.a.
Q4 2018	1	$6.3m	n.a.	n.a.
Q4 2020	2	$3.3m	n.a.	n.a.
Q1 2021	2	$4.4m	n.a.	n.a.
Q4 2023	1	$513k	1	0
Q1 2024	2	$2.0m	2	0
Q2 2024	1	$354k	1	1

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

MDXG and LLY →MDXG and JNJ →MDXG and VRTX →Choose a stock to compare with MDXG →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own MDXG, latest filings →Back to the 13F Explorer →

Provided for information purposes only, not financial advice. The holdings shown here and anything drawn from them are illustrative, produced from assumptions you control, and must not be relied on for any investment, financial or business decision. Read the full notice

Not advice, and not a recommendation. Everything L3VLUP publishes is provided for information purposes only. Nothing here is financial, investment, legal, tax or accounting advice, a personal recommendation, or an offer or solicitation to buy or sell any security or financial instrument. It takes no account of anyone’s objectives, financial situation or needs.

Not a regulated adviser. L3VLUP does not provide regulated financial services. Speak to a suitably qualified and regulated professional before acting on anything you read here.

Illustrative figures. Default values are plausible starting points chosen so a model has somewhere to begin. They are not data, not a view on any company, and not calibrated to anything. Outputs move with whatever you type in.

Third-party data. Where live figures appear they come from third parties, including public filings and market feeds. They may be delayed, incomplete, restated, mis-tagged at source or simply wrong, and their providers do not endorse or verify this page. Every figure links to where it came from. Check it there before relying on it. Past performance is not a guide to future performance.

Company names and logos. Names, tickers and logos are the trademarks of their owners and appear only to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, none of them took part in preparing the exercise, and nothing here is a statement by or about any of them. See third-party names and marks.

No warranty, and limited liability. This page is provided “as is” without warranty of any kind. To the fullest extent permitted by law, L3VLUP accepts no liability for any loss or damage arising from use of, or reliance on, anything on it. Nothing in this notice limits any liability that cannot lawfully be limited.

Full terms: Information Purposes and No Advice · Terms